Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice
about
Duchenne Muscular Dystrophy: From Diagnosis to TherapyLong-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension StudySerum Creatinine Distinguishes Duchenne Muscular Dystrophy from Becker Muscular Dystrophy in Patients Aged ≤3 Years: A Retrospective Study.Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients.How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouseSplice-switching antisense oligonucleotides as therapeutic drugsCurrent Translational Research and Murine Models For Duchenne Muscular Dystrophy.Systemic Antisense Therapeutics for Dystrophin and Myostatin Exon Splice Modulation Improve Muscle Pathology of Adult mdx Mice.Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx Mice.PGC-1α gene transfer improves muscle function in dystrophic muscle following prolonged disease progress.Dendrimer Conjugates for Light-activated Delivery of Antisense Oligonucleotides.Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues.Photobiomodulation therapy protects skeletal muscle and improves muscular function of mdx mice in a dose-dependent manner through modulation of dystrophin.Skipping Multiple Exons to Treat DMD-Promises and Challenges.
P2860
Q26784259-4C86CFE1-0332-408E-8C97-9BC7DF05353EQ33435110-67E48511-F3E9-4F45-BF57-1E9B0FC9F4ADQ33646732-74398209-8B39-45F3-BB11-F3AC0279D6EDQ34041966-6C190E86-BD5C-4B23-AF52-5CF4989493CEQ35821127-09E1A6AC-9E48-4FB3-A894-2A1C431F3DABQ37211004-9A7175F1-83E6-44C8-ABF4-34FCCFC13FC0Q37610505-27BD15AA-D4FF-4F3B-A523-51DA2BDDF05BQ37718154-B8CB279B-A123-4484-BB23-5D2D9118278CQ40956001-2DAE91A6-A6F9-4717-9DC6-01FEC68899B0Q41487839-05001A64-738F-402F-A826-67CCE3360874Q41573307-82799FBD-540A-49C5-91A9-55BEBFD231E7Q42380614-419A8205-64CC-4DF4-95E4-FB1341B1EBE1Q47325217-0C12E5A4-83EA-402F-9267-99629C0B3205Q52429827-76F6BF48-2211-402D-88BA-3A6752BE9780
P2860
Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Exon skipping restores dystrop ...... ater stage dystrophic dko mice
@ast
Exon skipping restores dystrop ...... ater stage dystrophic dko mice
@en
Exon skipping restores dystrop ...... ater stage dystrophic dko mice
@nl
type
label
Exon skipping restores dystrop ...... ater stage dystrophic dko mice
@ast
Exon skipping restores dystrop ...... ater stage dystrophic dko mice
@en
Exon skipping restores dystrop ...... ater stage dystrophic dko mice
@nl
prefLabel
Exon skipping restores dystrop ...... ater stage dystrophic dko mice
@ast
Exon skipping restores dystrop ...... ater stage dystrophic dko mice
@en
Exon skipping restores dystrop ...... ater stage dystrophic dko mice
@nl
P2093
P2860
P356
P1433
P1476
Exon skipping restores dystrop ...... ater stage dystrophic dko mice
@en
P2093
H M Moulton
L Marston-Poe
P2860
P2888
P304
P356
10.1038/GT.2014.53
P577
2014-06-19T00:00:00Z
P6179
1015245534